Cite
Omeprazole, a Gastric Proton Pump Inhibitor, Inhibits Melanogenesis by Blocking ATP7A Trafficking.
MLA
Matsui, Mary S., et al. “Omeprazole, a Gastric Proton Pump Inhibitor, Inhibits Melanogenesis by Blocking ATP7A Trafficking.” Journal of Investigative Dermatology, vol. 135, no. 3, Mar. 2015, pp. 834–41. EBSCOhost, https://doi.org/10.1038/jid.2014.461.
APA
Matsui, M. S., Petris, M. J., Niki, Y., Karaman-Jurukovska, N., Muizzuddin, N., Ichihashi, M., & Yarosh, D. B. (2015). Omeprazole, a Gastric Proton Pump Inhibitor, Inhibits Melanogenesis by Blocking ATP7A Trafficking. Journal of Investigative Dermatology, 135(3), 834–841. https://doi.org/10.1038/jid.2014.461
Chicago
Matsui, Mary S, Michael J Petris, Yoko Niki, Nevena Karaman-Jurukovska, Neelam Muizzuddin, Masamitsu Ichihashi, and Daniel B Yarosh. 2015. “Omeprazole, a Gastric Proton Pump Inhibitor, Inhibits Melanogenesis by Blocking ATP7A Trafficking.” Journal of Investigative Dermatology 135 (3): 834–41. doi:10.1038/jid.2014.461.